AstraZeneca made a major move today with its experimental COPD drug tozorakimab, reporting that the treatment significantly reduced moderate to severe flare ups of chronic obstructive pulmonary disease (COPD) in two late stage Phase III trials.
Eli Lilly’s eczema drug Ebglyss (lebrikizumab) is making waves with new long term data showing strong, lasting results for people with moderate to severe atopic dermatitis.
Over two transformative days, global and Indian thought leaders will explore the evolution of Good Manufacturing Practices toward a culture of quality maturity, transparency, and patient trust. Discussions will span audit readiness
Biocon Limited has named Shreehas Tambe as its new chief executive officer and managing director, effective April 1, 2026.
Chennai-based MGM Healthcare has set up what it says is the world’s largest intestinal rehabilitation programme and intestinal transplant programme in just three years, marking a significant step forward for advanced healthcare in India.
Indian Army hospital in high-altitude region received a major boost on Thursday as a new oxygen-generation facility was inaugurated in Arunachal Pradesh, strengthening critical healthcare access in one of the country’s toughest terrains.
Alkem Laboratories has announced the launch of its semaglutide injection in India, introducing a more affordable option for patients managing type 2 diabetes and weight issues.
Karnataka has just ordered a major change in maternity hospital rules to save lives during childbirth. The state government now requires every maternity hospital to have advance blood bank tie ups and ensure key doctors stay on site so mothers...
The U.S. Food and Drug Administration has approved a new oral treatment for psoriasis developed by Johnson & Johnson, offering patients a simpler and more convenient therapy option.
U.S.-based Merck & Co. has agreed to acquire Terns Pharmaceuticals in a $6.7 billion deal, as it looks to strengthen its cancer pipeline and reduce reliance on its blockbuster drug Keytruda.